Article
Predicting Minimal Residual Disease in Acute Myeloid Leukemia through Stochastic Modeling of Clonality
2019-10-02
Abstract excerpt
Event-free and overall survival remains poor for acute myeloid leukemia (AML). Chemo-resistant clones contributing to relapse of the disease arise from minimal residual disease (MRD) rather than resulting from newly acquired mutations during or after chemotherapy. MRD is the presence of measurable leukemic cells using non-morphologic assays. It is considered a strong predictor of relapse. The dynamics of clones co...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 94d74d4c-2d1c-563e-b33a-58bb8c92b15e
- DOI
- 10.1101/790261
